Related Experiment Video
Updated: Aug 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
Muriel J P van Kempen1, Judith S Vermeiren, Mario Vaneechoutte
1Department of Otorhinolaryngology, Ghent University Hospital, Belgium.
Insights
Pneumococcal conjugate vaccines did not reduce recurrent acute otitis media (AOM) in children, despite good immune responses. This study found no clinical protective effect for frequent AOM cases.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
- Otolaryngology
Background:
- The American Academy of Pediatrics recommends pneumococcal conjugate vaccines for infants with recurrent acute otitis media (AOM).
- Previous recommendations were based on trials in healthy infants, not specifically those with frequent AOM.
Purpose of the Study:
- To evaluate the efficacy of a 7-valent pneumococcal conjugate vaccine in preventing recurrent AOM.
- To assess the vaccine's immunogenicity and impact on nasopharyngeal Streptococcus pneumoniae carriage in children with a history of frequent AOM.
Main Methods:
- A double-blind, randomized study involving 74 Belgian children aged 1-7 years with at least two AOM episodes in the prior year.
- Participants received either a 7-valent pneumococcal conjugate vaccine with a booster or a control hepatitis A vaccine.
- Follow-up duration was 26 months.
Main Results:
- No significant reduction in AOM episodes was observed in the pneumococcal vaccine group compared to controls (rate ratio: 1.16).
- Nasopharyngeal pneumococcal carriage remained stable overall.
- A temporary shift in S. pneumoniae serogroups from vaccine-related to non-vaccine-related types was noted post-vaccination.
Conclusions:
- Pneumococcal conjugate vaccination showed no clinical protective effect against recurrent AOM in children with a history of frequent AOM.
- The findings suggest current recommendations may need re-evaluation for this specific pediatric population.
Background:
Based on two clinical trials in healthy infants the American Academy of Pediatrics (AAP) advices immunization with a 7-valent pneumococcal conjugate vaccine in children with recurrent acute otitis media (AOM).
Objective:
To study the efficacy of a 7-valent pneumococcal conjugate vaccine on acute otitis media recurrences, its immunogenicity and impact on nasopharyngeal Streptococcus pneumoniae carriage in children with a history of frequent acute otitis media.
Methods:
In this double-blind, randomized study, 74 Belgian children, aged 1-7 years, with at least 2 clinically diagnosed episodes of acute otitis media in the previous year were enrolled. Children were immunized with either a 7-valent pneumococcal conjugate vaccine followed by a 23-valent pneumococcal polysaccharide booster or a control hepatitis A vaccine. Total follow-up was 26 months.
Results:
Despite adequate serum IgG responses to all conjugate vaccine pneumococcal serotypes, no reduction of acute otitis media episodes was observed in the pneumococcal vaccine group as compared to the control group (rate ratio: 1.16; 95% CI: 0.69-1.96). Overall nasopharyngeal pneumococcal carriage remained stable. However, a transient shift from conjugate vaccine related S. pneumoniae serogroups to non-vaccine related serogroups was noted following conjugate vaccination.
Conclusion:
Clinically no protective effect of pneumococcal conjugate vaccination on acute otitis media recurrences was found in children with a history of frequent AOM.
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Tonsillitis II: Management
Streptococcal Pharyngitis
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
